James Ferguson
Equibles does not estimate personal net worth.
Get an email with a short summary when Cadrenal Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get CVKD alertsAbout James Ferguson
James Ferguson was last confirmed as Board Member at Matinas BioPharma Holdings, Inc. (MTNB) in a filing dated September 19, 2023. Matinas BioPharma Holdings, Inc. reported in an 8-K filed October 31, 2024 that James Ferguson was terminated as Chief Medical Officer, effective October 31, 2024. The proxy statement of Cadrenal Therapeutics, Inc. reports total compensation of $1,395,809 for James Ferguson in fiscal 2025, including a base salary of $457,414. Disclosed compensation is on record for 8 fiscal years. Cadrenal Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Cadrenal Therapeutics, Inc. includes John P. Sharp (CFO), Matthew K. Szot (CFO), Quang X. Pham (CFO, Chief Accounting Officer and Board Member) and 7 others.
“In connection with the Reduction in Force, the employment of James Ferguson, M.D., the Company's Chief Medical Officer, was terminated effective October 31, 2024.”
Affiliation history
-
Cadrenal Therapeutics, Inc. (CVKD)
Proxy statement
CurrentStart not stated–present
Last confirmed July 31, 2025
-
2019-01-01–2023-09-19
Last confirmed by a filing; no departure on record
-
Matinas BioPharma Holdings, Inc. (MTNB)
Source not stated
Start not stated–2024-10-31
Company network
Leadership on record at Cadrenal Therapeutics, Inc.
- John P. Sharp CFO
- Matthew K. Szot CFO
- Quang X. Pham CFO, Chief Accounting Officer, Board Member
- Jeffrey Cole COO
- Class I Directors Board Member
- Glynn Wilson Board Member
- John Murphy Board Member
- Lee Golden Board Member
- Lee Scott Golden, M.D. Board Member
- Robert Lisicki Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Cadrenal Therapeutics, Inc. (CVKD) | Former Chief Medical Officer | $457,414 | $1,395,809 |
| 2024 | Matinas BioPharma Holdings, Inc. (MTNB) | Former Chief Medical Officer | $468,000 | $589,680 |
| 2024 | Cadrenal Therapeutics, Inc. (CVKD) | Former Chief Medical Officer | — | — |
| 2023 | Matinas BioPharma Holdings, Inc. (MTNB) | Former Chief Medical Officer | $468,000 | $880,603 |
| 2022 | Matinas BioPharma Holdings, Inc. (MTNB) | Chief Medical Officer | $450,000 | $869,099 |
| 2021 | Matinas BioPharma Holdings, Inc. (MTNB) | Chief Medical Officer | $422,300 | $1,621,937 |
| 2020 | Matinas BioPharma Holdings, Inc. (MTNB) | Chief Medical Officer | $410,000 | $1,650,043 |
| 2019 | Matinas BioPharma Holdings, Inc. (MTNB) | Chief Medical Officer | $319,444 | $752,315 |
| 2018 | Matinas BioPharma Holdings, Inc. (MTNB) | Chief Medical Officer | — | — |